NorthWest Biotherapeutics Inc (NWBO)

[marzan]

MI Dendream, If LP chooses the approach of announcing topline by 3/29 by meeting the late breaker deadline of 3/28 and acceptance by 3/29, I think she follows the very beaten approach taken by successful biotechs who released their trial results in a prestigious conference in front of such a huge learned audience. This is how Amarin did on Sep 24 announcing topline after securing late breaker acceptance from AHA to be delivered later on Nov 10th at the AHA conference. I think JUNO or KITE did the same thing what you suggest and after their presentation at ASCO, I guess the B/O news surfaced. I agree it is so tight but if LP is already ready time wise meeting the 3/28 late breaker deadline, I think it would be fantastic for all of us. If not ready, then she probably goes with the other two options you listed subsequently. Lets see how next Friday goes for us. Good luck to all of us, Ardent Longs, and of course cancer patients around the world!